Copper(1+)
-
Copper(1+)
structure -
-
CAS No:
17493-86-6
-
Formula:
Cu
-
Chemical Name:
Copper(1+)
-
Synonyms:
Copper,ion (Cu1+);Cuprous ion;Copper(1+);Copper ion(1+);Copper ion (Cu+);Copper(I);Cuprous ion (Cu1+);Cuprous cation;Copper(I) ion;Cu1+
-
CAS No:
Description
Copper(1+) is a copper cation and a monoatomic monocation. It has a role as a cofactor.|Antihemophilic Factor, Human Recombinant is the recombinant form of human antihemophilic factor (AH)) (Factor VIII) with coagulation promoting activity. Antihemophilic factor binds to factor IXa in the coagulation cascade along with calcium and phospholipid. This complex converts factor X to the activated form, factor Xa. In turn, factor Xa/Va complex activates thrombin, which cleaves fibrinogen into fibrin, eventually resulting in blood clot formation.
Drug Information
Treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor-VIII deficiency).Advate does not contain von Willebrand factor in pharmacologically effective quantities and is therefore not indicated in von Willebrand disease.|Treatment of bleeding episodes in patients with acquired haemophilia caused by antibodies to Factor VIII. Obizur is indicated in adults.,|Treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor VIII deficiency).Iblias can be used for all age groups.|Treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor VIII deficiency). Kovaltry can be used for all age groups.|Treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor-VIII deficiency).This preparation does not contain von Willebrand factor and is therefore not indicated in von Willebrand's disease.|Treatment of hereditary factor VIII deficiency|Haemophilia A (congenital Factor VIII deficiency)
cuprous ion
Copper(1+) Use and Manufacturing
Human drugs -> Advate -> EMA Drug Category|Antihemorrhagics -> Human pharmacotherapeutic group|Human drugs -> Obizur -> EMA Drug Category|Human drugs -> Iblias -> EMA Drug Category|Human drugs -> Kovaltry -> EMA Drug Category|Human drugs -> Kogenate Bayer -> EMA Drug Category|Human drugs -> Helixate NexGen -> EMA Drug Category|Human drugs -> Rare disease (orphan)|Human Drugs -> EU pediatric investigation plans
Computed Properties
Molecular Weight:63.55
Exact Mass:62.929597
Monoisotopic Mass:62.929597
Heavy Atom Count:1
Formal Charge:1
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Learn More Other Chemicals
-
Xanthylium, 9-(2-carboxyphenyl)-3,6-bis(diethylamino)-, copper(1+) (OC-6-11)-hexakis(cyano-C)ferrate(4-) (2:2:1)
79665-42-2
-
Methanesulfonic acid, trifluoro-, copper(1+) salt, compd. with benzene (2:2:1)
42152-46-5
-
2-Propenoic acid, copper(1+) salt
41380-06-7
-
Mercurate(2-), tetraiodo-, copper(1+) (1:2), (T-4)- Formula
13876-85-2